Latest News

Quality of Life Improvements after Psoriasis Cal/BD Aerosol Foam Treatment
Quality of Life Improvements after Psoriasis Cal/BD Aerosol Foam Treatment

April 2nd 2025

Positive changes in DLQI scores were observed after 4 weeks of therapy as well as the 6-month follow-up.

Guselkumab Shows Strong Response in Long-Term Subtype Psoriasis Study
Guselkumab Shows Strong Response in Long-Term Subtype Psoriasis Study

April 2nd 2025

PASI and QoL: A New Approach to Treatment Goals
PASI and QoL: A New Approach to Treatment Goals

March 31st 2025

Patient and Physician Perspectives Assess Long-Term Impact of Tildrakizumab for Psoriasis
Patient and Physician Perspectives Assess Long-Term Impact of Tildrakizumab for Psoriasis

March 27th 2025

Biologics Targeting IL-12, IL-23, and IL-17 Reduce Serious Infections in Older Adults with Psoriatic Disease
Biologics Targeting IL-12, IL-23, and IL-17 Reduce Serious Infections in Older Adults with Psoriatic Disease

March 25th 2025

Latest CME Events & Activities

Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making

View More

Melanoma Tumor Board: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies

March 31, 2025

Register Now!

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

View More

Revolutionizing Atopic Dermatitis (RAD) Conference 2025

June 6-7, 2025

Register Now!

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

July 26, 2025

Register Now!

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

View More

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

View More

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

View More

© 2025 MJH Life Sciences

All rights reserved.